INVESTIGATION OF EPIGENETIC MECHANISM OF ALCOHOL USE DISORDER IN VIVO

被引：0
|
作者：
Wang, C. [1 ,2 ]
Weiss, R. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[2] McLean Hosp, Div Alcohol & Drug Abuse, Belmont, MA 02478 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2018年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
375
引用
收藏
页码：112A / 112A
页数：1
相关论文
共 50 条
  • [21] Alcohol and aging: Next-generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorder
    Perlstein, Tyler A.
    Jung, Jeesun
    Wagner, Alexandra C.
    Reitz, Joshua
    Wagner, Josephin
    Rosoff, Daniel B.
    Lohoff, Falk W.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2025,
  • [22] EPIGENETIC AGE ACCELERATION IN ALCOHOL USE DISORDER: EVIDENCE FOR A NOVEL ROLE OF APOL2
    Loho, F. W.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 35A - 35A
  • [23] Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2
    Audrey Luo
    Jeesun Jung
    Martha Longley
    Daniel B. Rosoff
    Katrin Charlet
    Christine Muench
    Jisoo Lee
    Colin A. Hodgkinson
    David Goldman
    Steve Horvath
    Zachary A. Kaminsky
    Falk W. Lohoff
    Neuropsychopharmacology, 2020, 45 : 327 - 336
  • [24] Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
    Hilal, Fahd Francois
    Jeanblanc, Jerome
    Deschamps, Chloe
    Naassila, Mickael
    Pierrefiche, Olivier
    Ben Hamida, Sami
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (05) : 525 - 561
  • [25] Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2
    Luo, Audrey
    Jung, Jeesun
    Longley, Martha
    Rosoff, Daniel B.
    Charlet, Katrin
    Muench, Christine
    Lee, Jisoo
    Hodgkinson, Colin A.
    Goldman, David
    Horvath, Steve
    Kaminsky, Zachary A.
    Lohoff, Falk W.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (02) : 327 - 336
  • [26] Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial
    Schacht, Joseph P.
    Hoffman, Michaela
    Chen, Brian H.
    Anton, Raymond F.
    PHARMACOGENOMICS JOURNAL, 2022, 22 (01): : 1 - 8
  • [27] Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)
    Bourguet, Erika
    Ozdarska, Katarzyna
    Moroy, Gautier
    Jeanblanc, Jerome
    Naassila, Mickael
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 1745 - 1766
  • [28] Neuronal Metabolic-Epigenetic Exchange in the Regulation of Behavior - Implications for Alcohol Use Disorder and Beyond
    Egervari, Gabor
    Alexander, Desi
    Mendoza, Mariel
    Lombroso, Sonia
    Donahue, Greg
    Mews, Philipp
    Lee, Virginia
    Garcia, Benjamin
    Berger, Shelley
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 430 - 430
  • [29] EPIGENETIC AGE ACCELERATION IN ALCOHOL USE DISORDER: EVIDENCE FOR A NOVEL ROLE OF APOL2
    Luo, Audrey
    Jung, Jeesun
    Longley, Martha
    Rosoff, Daniel
    Charlet, Katrin
    Muench, Christine
    Lee, Jisoo
    Hodgkinson, Colin
    Goldman, David
    Horvath, Steve
    Kaminsky, Zachary
    Lohoff, Falk
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S191 - S191
  • [30] ANALYSIS OF EPIGENETIC PROFILES IN POSTMORTEM HUMAN BRAIN SAMPLES FROM INDIVIDUALS WITH ALCOHOL USE DISORDER
    Zillich, L.
    Streit, F.
    Witt, S. H.
    Rietschel, M.
    Frank, J.
    Friske, M.
    Sirignano, L.
    Foo, J. C.
    Noethen, M. M.
    Degenhardt, F.
    Hansson, A.
    Spanagel, R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 : 10 - 10
12345